Saliba, R. M., Srour, S., Hosing, C., Rondon, G., Kaur, I., Popat, U., Oran, B., Kebriaei, P., Alousi, A., Alatrash, G., Mehta, R., Martinez, C., Straubel, M., Tanner, M., Olson, A., Fingrut, W., Ramdial, J., Aljawai, Y., Smallbone, P., Rezvani, K., Shpall, E., Champlin, R. (2025). CD34+/TNC ratio predicts relapse in AML/MDS patients receiving peripheral blood matched allogeneic stem cell transplantation with post-transplant cyclophosphamide. Blood. https://doi.org/10.1182/blood-2025-5994